Tharanga Lanka Weerawardana
Alaris Lanka Pvt Ltd conducted a press conference recently to explain to the media regarding the false rumours about their brand “Facia Premium”.
Mr. Tharanga Lanka Weerawardana, Chairman and the Managing Director of Alaris Group of Companies stated that a false letter baring the letterhead of the National Medicine Regulatory Authority and forged signature of Dr. Kamal Jayasinghe who is the CEO of the National Medicines Regulatory Authority stating that the product Facia Premium has been banned has been circulated in some print and social media.
The CEO of NMRA has denied the issuance of such letter and instructed the Director of the Fraud Investigation Bureau to conduct an investigation on priority basis.
Sri Lanka grants approval for emergency use of Oxford-AstraZeneca vaccine
chinadaily.com.cn - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from chinadaily.com.cn Daily Mail and Mail on Sunday newspapers.
Sri Lanka approves vaccine amid warnings of virus sprea
accesswdun.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from accesswdun.com Daily Mail and Mail on Sunday newspapers.